Efficacy of Hepatitis-B vaccine in children from 12 to 16 months in Mashad health centers

Azarkar, Z

Volume 7, Issue 5 (winter 2004) 2004, 7(5): 38-41 | Back to browse issues page

Mendeley

Zotero

RefWorks

Azarkar Z. Efficacy of Hepatitis-B vaccine in children from 12 to 16 months in Mashad health centers. Journal of Inflammatory Diseases. 2004; 7 (5) :38-41
URL: http://journal.qums.ac.ir/article-1-401-en.html

Efficacy of Hepatitis-B vaccine in children from 12 to 16 months in Mashad health centers

Z Azarkar ^*

Abstract: (12689 Views)

Background: More than 5% of the people are chronic carriers of HBV. Hepatitis B and its complications are problem around the world . Immunization is the best method for prophylaxis. Objective: This study was conducted in order to evaluate the efficacy of HBV vaccine and to measure the anti-HBs Ag titer. Methods: We collected serum sample from 100 infants, who were 12-16Mo. Old and vaccinated three times (based on Iran immunization program) during 1997. Serum samples were collected from individuals 3-6 month after third vaccination and tested for anti-HBs Ag by ELISA . Findings: Of 100 infants, 81 individuals have anti-HBs Ag after immunization that they were 40 (42.36%) males and 41 (50.62%) females. The average anti-HBs Ag productions in males were 1236 mlu/dl and in females were 1282 mlu/dl. Mean of all samples was 1213 mlu/dl . The lower limit was 100 unit and upper limit was 1600 unit. Lower and upper limits were in infants 15 Mo.Old. The efficacy of HBV vaccine (Heberbiovac-Hb) in infants 12-16 Mo.Old was 81%. Conclusion: The study shows that our results were different from textbooks and high percentage of infants, haven’t anti-HBs Ag after immunization

Keywords: Anti-HBs Ag, Immunization, Hepatitis B

Full-Text [PDF 149 kb] (4371 Downloads)

Type of Study: Research | Subject: Infectious Disease

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb